Shares of GameStop (GME) rocketed higher at market open today continuing the battle between retail investors and instutional investors. GameStop, a brick-and-mortar video game retailer, has been a popular short target on Wall Street. In fact, more than 138% of…
This should be an exiting week for Relief Therapeutic (OTC:RLFTF) investors. The company is expected to release topline data results and other information during the week for their Phase 2B/3 Trial of Zyesami. According to a previous release, no drug-related…
Aurcana Silver (OTC:AUNFF) acquired the historic Revenue Virginius Mine in Ouray Colorado in December 2018. This is a mine that has come in and out of production a number of times with the ebb and flow of demand since the…
Shares of GameStop (GME) surged 69% by a subreddit called WallStreetBets. In the battle between short-seller Citron Research and an army of Reddit-charged day traders, GameStop’s seemingly endless rally to an all-time high has given the stock’s bulls a win,…
Atossa Therapeutics (ATOS) is a clinical-stage biopharmaceutical company seeking to discover and develop innovative medicines in areas of significant unmet medical need. Atossa’s current focus is on breast cancer and COVID-19. I believe our innovative therapies and delivery methods can…
Yesterday, President Biden has signed an executive order to improve and expand access to COVID-19 treatments. This executive order will help accelerate the development of novel therapies for the most promising COVID-19 interventions. This bill comes as a means for…
Shares of Novan (NOVN) stock has surged 10% on the company getting granted patent on Nitric Oxide Releasing Compositions in Europe. This most likely is connecting to their inhalent drug for COVID-19.
Greenlane Renewables (GRN) could be a huge green energy stock to look at. The biogas is released into the atmosphere with the decomposition of organic waste. This biogas is generated by the anaerobic decomposition of organic matter can be turned…
Shares of Caladrius Biosciences (CLBS) are surging after H.C. Wainwright initiated a buy rating with a price target of $14. Caladrius Biosciences is an American biopharmaceutical company active in the field of stem cell therapy and regenerative medicine, particularly of…
Aclaris Therapeutics (ACRS), a clinical-stage biopharmaceutical company focused on developing novel drug candidates for immuno-inflammatory diseases, today announced positive preliminary topline results from a 12-week, Phase 2a, multicenter, randomized, investigator and patient-blind, sponsor-unblinded, parallel group, placebo-controlled clinical trial to investigate…
We use cookies to ensure that we give you the best experience on our website.
